Cellectis Reports Third Quarter and First Nine Months 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cellectis (CLLS) Misses Q2 EPS by 5c
November 16, 2015 5:02 PM ESTCellectis (NASDAQ: CLLS) reported Q2 EPS of (EUR0.36), EUR0.05 worse than the analyst estimate of (EUR0.31). Revenue for the quarter came in at EUR1 million versus the consensus estimate of EUR5.6 million.
As of September 30, 2015 Cellectis had 279.4 million in cash and cash equivalents compared to... More
